drug · antibody
obexelimab
Phase 3updated 3mo agoby $ZBIO Zenas BioPharma, Inc.🔗 ChEMBL
Phase 3community read0 votes
Antibody drug with a maximum clinical stage of Phase 3 (across all indications), with 4 investigational indications.
targets
B-lymphocyte antigen CD19Low affinity immunoglobulin gamma Fc region receptor II-b
all catalysts(0)
nothing on the calendar yet
Trials studying obexelimab
- phase2A Study of Obexelimab in Patients With Systemic Lupus Erythematosus
- phase3A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease
- phase2A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone)
- phase3A Study of Obexelimab in Patients With Warm Autoimmune Hemolytic Anemia (SApHiAre)
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 34m ago
Found something off?
comments(0)
5-min edit window · permanent after that